3337 Safety and effectiveness analysis of V600 BRAF-mutated metastatic melanoma (MM) patients (pts) from the dabrafenib (D) plus trametinib (T) named patient programme (NPP) - DESCRIBE II study. (September 2015) - Atkinson, V.; Thienen, J.V.; McArthur, G.; Hospers, G.; Long, G.; Carnevale-Schianca, F.; Tulyte, S.; Stein, D.; Bassel, M.; Freivogel, K.; Dalland, L.; Lau, M.; et al.